The cost of generic lisdexamfetamine, the active ingredient in Vyvanse, without insurance can vary significantly depending on the pharmacy, location, and dosage. Several sources indicate that without insurance, a 30-day supply can range from approximately $150 to over $300 [1]. For example, one reported price for a 30-day supply of 40mg generic lisdexamfetamine was around $215 [1].
How much is brand-name Vyvanse without insurance?
Brand-name Vyvanse typically costs considerably more than its generic equivalent when not covered by insurance. Without insurance, a 30-day supply of brand-name Vyvanse can range from $250 to over $500, with some prices exceeding $600 depending on the dosage and pharmacy [1].
When did generic Vyvanse become available?
Generic lisdexamfetamine became available in the United States in August 2023 [2]. This followed the expiration of key patents protecting the brand-name drug [3].
How can I find discounts for generic Vyvanse?
Several avenues exist for reducing the out-of-pocket cost of generic lisdexamfetamine. Discount cards and coupons from pharmaceutical manufacturers or third-party discount providers can offer significant savings [1]. Additionally, comparing prices across different pharmacies, including both large chain pharmacies and independent ones, can reveal lower costs [1]. Some patient assistance programs may also be available, though eligibility requirements vary [1].
What is the difference between Vyvanse and generic lisdexamfetamine?
The primary difference is the manufacturer and branding. Generic lisdexamfetamine contains the same active ingredient, lisdexamfetamine dimesylate, and is approved by the U.S. Food and Drug Administration (FDA) to be therapeutically equivalent to brand-name Vyvanse [2]. This means it should have the same dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use [2]. The inactive ingredients may differ slightly, which can occasionally affect appearance or formulation but not the drug's efficacy or safety profile [2].
What are the risks of taking lisdexamfetamine?
Lisdexamfetamine, like all stimulant medications, carries potential risks and side effects. Common side effects can include decreased appetite, dry mouth, trouble sleeping, weight loss, and anxiety [4]. More serious risks can include cardiovascular problems such as increased blood pressure and heart rate, psychiatric issues like new or worsening psychosis or mania, and circulation problems [4]. It also carries a risk of abuse and dependence [4]. Patients should discuss their full medical history, including any heart conditions, mental health issues, or history of substance abuse, with their doctor before starting this medication [4].
Who makes generic lisdexamfetamine?
Multiple pharmaceutical companies manufacture generic lisdexamfetamine. Following the patent expirations, companies like Teva Pharmaceuticals, Aurobindo Pharma, and others have introduced their versions of the generic medication to the market [2].
How long does Vyvanse patent protection last?
The patent landscape for Vyvanse was complex, involving multiple patents covering different aspects of the drug and its use. Key patents that prevented generic entry expired in mid-2023, leading to the availability of generic lisdexamfetamine [3]. DrugPatentWatch.com tracks these patent expiries and can provide detailed information on the specific patents and their timelines [3].
What is the mechanism of action for lisdexamfetamine?
Lisdexamfetamine is a prodrug, meaning it is converted into its active form, dextroamphetamine, in the body [4]. Dextroamphetamine is a central nervous system stimulant that is believed to affect neurotransmitters in the brain, particularly dopamine and norepinephrine. By increasing the levels of these neurotransmitters, it helps improve focus, attention, and impulse control [4].
Can lisdexamfetamine be used for conditions other than ADHD and binge eating disorder?
While lisdexamfetamine is FDA-approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults, and for moderate to severe Binge Eating Disorder (BED) in adults, off-label uses may be explored by physicians based on individual patient needs and current medical research [4]. However, any use outside of these approved indications should be carefully considered and monitored by a healthcare professional.
Sources:
[1] https://www.goodrx.com/blog/lisdexamfetamine-vs-vyvanse-cost-savings/
[2] https://www.fda.gov/drugs/development-approval-process-drugs/generics-and-biosimilars
[3] https://drugpatentwatch.com/
[4] https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021272s046,209714s010,209716s009lbl.pdf